Join us for a panel discussion exploring the challenges and strategies for developing AI Governance programs tailored to different company sizes and global landscapes, particularly in the pharmaceutical sector. Learn how mid-sized and large companies overcome obstacles in scaling oversight, managing cross-border complexities, and harmonizing AI governance practices across regions with varying regulations.